Tisagenlecleucel

Tisagenlecleucel is an advanced cancer treatment known as a CAR T-cell therapy. It is designed for certain blood cancers, such as some types of leukemia and lymphoma. The process involves collecting a patient's immune cells (T cells), modifying them in a lab to better recognize and attack cancer cells, and then re-infusing these enhanced cells back into the patient. This personalized therapy helps the immune system specifically target and destroy cancer cells, offering new hope for patients with difficult-to-treat blood cancers.